FDA approved - Search News

Crohn's disease, US FDA

US FDA approves expanded use of Lilly's bowel disease drug

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's disease, a type of chronic inflammatory bowel disease (IBD). The drug, branded as Omvoh,

The Wall Street Journal on MSN · 14h

Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain.

YAHOO!Finance · 2h

Lilly gains US FDA approval for Omvoh to treat Crohn’s disease

Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat moderately to severely active Crohn's disease in the adult population. This is the second inflammatory bowel disease indication for the therapy in the US, after its approval for ulcerative colitis (UC) treatment in October 2023.

Columbia Missourian · 1h

FDA approves first new schizophrenia drug in more than 30 years

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

FDA red food dye ban

NBC News on MSN · 16h

FDA bans Red Dye No. 3, artificial coloring used in beverages, candy and other foods

The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a synthetic dye that gives food and drinks their bright red cherry color but has been linked to cancer in animals.

USA TODAY on MSN · 13h

FDA bans Red No. 3 food dye in food, drinks: Here's what to know

The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.

The Associated Press on MSN · 11h

FDA bans red dye No. 3 from foods

U.S. regulators are banning the dye called Red 3 from the food supply. The move comes nearly 35 years after the dye was barred from cosmetics such as lipsticks because of potential cancer risk.

STAT1d

Federal watchdog raises some concerns about the FDA’s accelerated approval program

The Office of Inspector General reviewed the FDA’s use of accelerated approval for 24 drugs, ultimately finding issues with ...

BioPharma Dive19h

Federal watchdog cites concerns with FDA’s accelerated approval process

The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...

FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

22h

BridgeBio Pharma Is A Buy On Dips After Attruby's FDA Approval

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...

2don MSN

Billed as nonaddictive, new pain pill could soon win FDA approval

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

3don MSN

Only FDA-approved vape products are available for purchase in Kentucky. Here's what to know

In 2024, the General Assembly passed House Bill 11, which limits vape products that can be sold in Kentucky.

Cure Today14h

The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Hosted on MSN19h

Tempus AI announces national launch of FDA-approved xT CDx test

Tempus AI (TEM) announced the national launch of the company’s FDA-approved, NGS-based in vitro diagnostic device, xT CDx.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Crohn's disease, US FDA

FDA red food dye ban

Related topics